ResearcherIstituto Tumori BariActive in the last 2 years
Michele Ammendola
Matched on ORCID iD 0000-0001-8043-6100; OpenAlex author ID A5007548728. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers
Papers 7
- What are the true benefits of robotic pancreaticoduodenectomy for patients with pancreatic cancer? Co-author DOI 10.1080/17474124.2024.2351398↗
- Close relationship between mediators of inflammation and pancreatic cancer: Our experience. First author DOI 10.3748/wjg.v30.i23.2927↗
- Chymase-positive Mast cells correlate with tumor angiogenesis: first report in pancreatic cancer patients. Co-author DOI 10.26355/eurrev_202111_27234↗
- Systematic Review of Irreversible Electroporation Role in Management of Locally Advanced Pancreatic Cancer. Co-author DOI 10.3390/cancers11111718↗
- The density of mast cells c-Kit+ and tryptase+ correlates with each other and with angiogenesis in pancreatic cancer patients. Co-author DOI 10.18632/oncotarget.19716↗
- Microvascular density and endothelial area correlate with Ki-67 proliferative index in surgically-treated pancreatic ductal adenocarcinoma patients. Co-author DOI 10.3892/ol.2015.3286↗
- Mast cells density positive to tryptase correlates with angiogenesis in pancreatic ductal adenocarcinoma patients having undergone surgery. Co-author DOI 10.1155/2014/951957↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Francesca Vescio · 2 shared papers, 2024 · strength 0.53
- Silvia Curcio · 1 shared paper, 2024 · strength 0.31
- Adam Enver Frampton · 2 shared papers, 2017–2024 · strength 0.28
- Cosmo Damiano Gadaleta · 4 shared papers, 2014–2021 · strength 0.27
- Paper Chymase-positive Mast cells correlate with tumor angiogenesis: first report in pancreatic cancer patients. DOI 10.26355/eurrev_202111_27234↗
- Paper The density of mast cells c-Kit+ and tryptase+ correlates with each other and with angiogenesis in pancreatic cancer pa… DOI 10.18632/oncotarget.19716↗
- Paper Microvascular density and endothelial area correlate with Ki-67 proliferative index in surgically-treated pancreatic du… DOI 10.3892/ol.2015.3286↗
- Nabeel Merali · 1 shared paper, 2024 · strength 0.22
- Irena Stefanova · 1 shared paper, 2024 · strength 0.22
- Girolamo Ranieri · 2 shared papers, 2014–2021 · strength 0.16
- Tullio Piardi · 2 shared papers, 2017–2019 · strength 0.15
- Paper Systematic Review of Irreversible Electroporation Role in Management of Locally Advanced Pancreatic Cancer. DOI 10.3390/cancers11111718↗
- Paper The density of mast cells c-Kit+ and tryptase+ correlates with each other and with angiogenesis in pancreatic cancer pa… DOI 10.18632/oncotarget.19716↗
- Riccardo Memeo · 2 shared papers, 2017–2019 · strength 0.15
- Paper Systematic Review of Irreversible Electroporation Role in Management of Locally Advanced Pancreatic Cancer. DOI 10.3390/cancers11111718↗
- Paper The density of mast cells c-Kit+ and tryptase+ correlates with each other and with angiogenesis in pancreatic cancer pa… DOI 10.18632/oncotarget.19716↗
- Carmelo Laface · 1 shared paper, 2021 · strength 0.12
- Girolamo Ranieri · 2 shared papers, 2015–2017 · strength 0.10
- Paper The density of mast cells c-Kit+ and tryptase+ correlates with each other and with angiogenesis in pancreatic cancer pa… DOI 10.18632/oncotarget.19716↗
- Paper Microvascular density and endothelial area correlate with Ki-67 proliferative index in surgically-treated pancreatic du… DOI 10.3892/ol.2015.3286↗
- Stefano Lafranceschina · 1 shared paper, 2019 · strength 0.09
- Oronzo Brunetti · 1 shared paper, 2019 · strength 0.09
- Nicola Silvestris · 1 shared paper, 2019 · strength 0.09
- Patrick Pessaux · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.